Jennifer Tseng, MD
James B. Utley Professor
Boston University School of Medicine
Dept of Surgery

MD, University of California, San Francisco
MPH, Harvard School of Public Health



Dr. Tseng is a highly regarded surgical oncologist and gastrointestinal surgeon, whose practice encompasses the upper gastrointestinal tract. She has led a group of diverse BIDMC faculty in oncology research, education and care for GI, endocrine, breast, as well as melanomas and sarcomas, and other malignancies.

Dr. Tseng has published more than 100 peer-reviewed journal articles on reducing surgical risk, cancer biomarkers and on developing models for cancer treatment sequencing strategies, with a strong focus on racial and socioeconomic disparities in care, an important BMC and BUSM mission. She has collaborated with the Massachusetts Department of Public Health to assess the impact of factors including insurance, disparities and health care reform on cancer diagnosis, treatment and prevention. She was the Founding Director of SOAR (Surgical Outcomes Analysis & Research) at UMass in 2007, a research initiative to improve treatment strategies for a broad range of surgical conditions and to develop tools to assess and reduce risk. At BIDMC, she and her co-leaders have led the continued development of SOAR as a health services and outcomes research group.

Dr. Tseng is also a dedicated educator of medical students and residents who has mentored numerous trainees throughout her research career.

Chair
Boston University School of Medicine
Surgery


Chief
Boston Medical Center
Surgery







Yr Title Project-Sub Proj Pubs
2001 DEVELOPMENT OF PANCREATIC TUMOR VACCINES 5F32CA086420-02 3
2000 DEVELOPMENT OF PANCREATIC TUMOR VACCINES 1F32CA086420-01 3
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Morgan R, Cassidy M, DeGeus SWL, Tseng J, McAneny D, Sachs T. Presentation and Survival of Gastric Cancer Patients at an Urban Academic Safety-Net Hospital. J Gastrointest Surg. 2018 Aug 10.View Related Profiles. PMID: 30097966.
     
  2. Paracha M, Hirsch AE, Tseng JF, McAneny DB, Sachs TE. Scholarly impact of student authorship on surgical research. Am J Surg. 2018 Aug 02.View Related Profiles. PMID: 30086832.
     
  3. Johnson AC, Ethun CG, Liu Y, Lopez-Aguiar AG, Tran TB, Poultsides G, Grignol V, Howard JH, Bedi M, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Delman KA, Wood WC, Cardona K, Maithel SK. Studying a Rare Disease Using Multi-Institutional Research Collaborations vs Big Data: Where Lies the Truth? J Am Coll Surg. 2018 Jun 12. PMID: 29906615.
     
  4. van Roessel S, Kasumova GG, Tabatabaie O, Ng SC, van Rijssen LB, Verheij J, Najarian RM, van Gulik TM, Besselink MG, Busch OR, Tseng JF. Pathological Margin Clearance and Survival After Pancreaticoduodenectomy in a US and European Pancreatic Center. Ann Surg Oncol. 2018 Jun; 25(6):1760-1767. PMID: 29651577.
     
  5. Fadayomi AB, Kasumova GG, Tabatabaie O, de Geus SWL, Kent TS, Ng SC, Moser AJ, Callery MP, Ashley SW, Tseng JF. Unique predictors and economic burden of superficial and deep/organ space surgical site infections following pancreatectomy. HPB (Oxford). 2018 Jul; 20(7):658-668. PMID: 29526467.
     
  6. Qian ZR, Rubinson DA, Nowak JA, Morales-Oyarvide V, Dunne RF, Kozak MM, Welch MW, Brais LK, Da Silva A, Li T, Li W, Masuda A, Yang J, Shi Y, Gu M, Masugi Y, Bui J, Zellers CL, Yuan C, Babic A, Khalaf N, Aguirre A, Ng K, Miksad RA, Bullock AJ, Chang DT, Tseng JF, Clancy TE, Linehan DC, Findeis-Hosey JJ, Doyle LA, Thorner AR, Ducar M, Wollison B, Laing A, Hahn WC, Meyerson M, Fuchs CS, Ogino S, Hornick JL, Hezel AF, Koong AC, Wolpin BM. Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma. JAMA Oncol. 2018 Mar 08; 4(3):e173420. PMID: 29098284.
     
  7. de Geus SWL, Kasumova GG, Sachs TE, Ng SC, Kent TS, Moser AJ, Vahrmeijer AL, Callery MP, Tseng JF. Neoadjuvant therapy affects margins and margins affect all: perioperative and survival outcomes in resected pancreatic adenocarcinoma. HPB (Oxford). 2018 Jun; 20(6):573-581.View Related Profiles. PMID: 29426635.
     
  8. Matiotti-Neto M, Eskander MF, Tabatabaie O, Kasumova G, Bliss LA, Ng SC, Tawa NE, Murphy B, Critchlow JF, Tseng JF. Percutaneous versus Cut-Down Technique for Indwelling Port Placement. Am Surg. 2017 Dec 01; 83(12):1336-1342. PMID: 29336750.
     
  9. Klompmaker S, Zoggel DV, Watkins AA, Eskander MF, Tseng JF, Besselink MG, Moser AJ. Nationwide Evaluation of Patient Selection for Minimally Invasive Distal Pancreatectomy Using American College of Surgeons' National Quality Improvement Program. Ann Surg. 2017 Dec; 266(6):1055-1061. PMID: 27607097; DOI: 10.1097/SLA.0000000000001982;.
     
  10. Morales-Oyarvide V, Rubinson DA, Dunne RF, Kozak MM, Bui JL, Yuan C, Qian ZR, Babic A, Da Silva A, Nowak JA, Khalaf N, Brais LK, Welch MW, Zellers CL, Ng K, Chang DT, Miksad RA, Bullock AJ, Tseng JF, Swanson RS, Clancy TE, Linehan DC, Findeis-Hosey JJ, Doyle LA, Hornick JL, Ogino S, Fuchs CS, Hezel AF, Koong AC, Wolpin BM. Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival. Br J Cancer. 2017 Dec 05; 117(12):1874-1882. PMID: 28982112.
     
Showing 10 of 139 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 137 publications over 21 distinct years, with a maximum of 22 publications in 2010

YearPublications
19951
19962
19972
19992
20001
20022
20042
20053
20063
20076
20086
200919
201022
20119
20127
20138
20144
20157
201615
201711
20185
Contact for Mentoring:


830 Harrison Avenue (Moakley), Suite 3400
Boston MA 02118
Google Map


Tseng's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department